According to BioNexus Gene Lab's latest financial reports the company's current EPS (TTM) is -$0.07327. In 2022 the company made an earnings per share (EPS) of -$0.03861 a decrease over its 2021 EPS that were of $0.05849.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.06807 | 76.28% |
2022 | -$0.03861 | -166.02% |
2021 | $0.05849 | -74.82% |
2020 | $0.23 | -600.17% |
2019 | -$0.04644 |